A322970 Share Price Performance
₩0
-2375.00 (-100.00%)
Price ₩0
Share Pricen/a
Moogene Medi Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A322970 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Moogene Medi Co., Ltd. Key Details
About A322970
- Founded
- 2016
- Employees
- n/a
- CEO
- WebsiteView website
Moogene Medi Co., Ltd. develops nanobiotechnology-based drug delivery systems. It develops lipid nanoparticle (LNP) materials for pharmaceutical protein delivery; RNP (sgRNA+ CRISPR Cas9)-encapsulated LNP for gene therapy; novel therapy for colorectal or pancreatic cancer with anticancer drug resistance due to genetic mutation by using RNP-encapsulated LNP; and topical treatment for androgenic alopecia therapy. The company was founded in 2016 and is headquartered in Hanam-si, South Korea.
